+467.0%
MRNA vs VTEB
+0.4%
+466.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VTEB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.4% | +5.0% | +1.3% |
| 7D | -1.1% | -0.9% | -0.2% | +10.4% |
| 30D | +126.1% | -2.5% | +128.6% | +206.4% |
| 3M | +190.0% | -3.0% | +193.0% | +307.7% |
| 6M | +157.2% | -2.1% | +159.4% | +252.2% |
| YTD | +388.2% | -1.5% | +389.7% | +524.4% |
| 1Y | +467.0% | +0.2% | +466.9% | +526.8% |
| All | +467.0% | +0.4% | +466.7% | +526.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VTEB.
Daily Out/Under-Performance
Portfolio return minus VTEB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VTEB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VTEB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling